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Available online 29 January 2008AbstractWe studied hippocampal cellular proliferation and neurogenesis processes in a model of transient global cerebral ischemia in gerbils by
labelling dividing cells with 50-Bromo-20-deoxyuridine (BrdU). Surrounding the region of selective neuronal death (CA1 pyramidal layer of the
hippocampus), an important increase in reactive astrocytes and BrdU-labelled cells was detected 5 days after ischemia. A similar result was found
in the dentate gyrus (DG) 12 days after ischemia. The differentiation of the BrdU+ cells was investigated 28 days after BrdU administration by
analyzing the morphology, anatomic localization and cell phenotype by triple fluorescent labelling (BrdU, adult neural marker NeuN and DNA
marker TOPRO-3) using confocal laser-scanning microscopy. This analysis showed increased neurogenesis in the DG in case of ischemia and triple
positive labelling in some newborn cells in CA1. Seven brain hemispheres from gerbils subjected to ischemia did not develop CA1 neuronal death;
hippocampus from these hemispheres did not show any of the above mentioned findings. Our results indicate that ischemia triggers proliferation in
CA1 and neurogenesis in the DG in response to CA1 pyramidal neuronal death, independently of the reduced cerebral blood flow or the cell
migration from subventricular zone (SVZ).
# 2008 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.
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Stroke is the third most common cause of death in developed
countries, exceeded only by coronary heart disease and cancer;
also, represents the first cause of permanent disability above the
age of 65 years. Despite that a restorative treatment has not been
reached yet.
The adult central nervous system contains stem cells that are
capable of generating new neurons, astrocytes and oligoden-
drocytes (Emsley et al., 2005). It has been suggested that
increased neurogenesis originating from stem cells located in
subventricular zone (SVZ) and subgranular zone (SGZ) of the
hippocampal dentate gyrus (DG) of adult brain in a variety of
mammals, including humans, may promote morphological and
functional recovery after cerebral ischemia, traumatic and
primary degenerative brain diseases (Gould et al., 1999; Schmidt
and Reymann, 2002).* Corresponding author. Tel.: +34 948 194700; fax: +34 948 194715.
E-mail addresses: pscolocho@alumni.unav.es, pabloesalazar@gmail.com
(P. Salazar-Colocho).
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doi:10.1016/j.neures.2008.01.008It is known that transient global cerebral ischemia leads to
delayed cell death of CA1 pyramidal neurons of the
hippocampus in adult gerbils (Kirino, 1982; Schmidt-Kastner
and Freund, 1991; Hara et al., 1993; Ferrer et al., 1997;
Horiguchi et al., 2002), and that brain ischemia increases
neurogenesis in the DG of the hippocampus of rodents
including gerbils (Takagi et al., 1999; Sharp et al., 2002; Kokaia
and Lindvall, 2003).
The origin of neural stem cells that give rise to new neurons
in the adult CNS has been a subject of debate. Although neural
progenitor proliferation and neurogenesis occur in SVZ and
SGZ, several studies have demonstrated the production of new
neurons in many other regions of the adult mammalian brain
including CA1 area of gerbils after global cerebral ischemia
(Schmidt and Reymann, 2002).
This and other issues like the mechanisms that trigger and
regulate the proliferation and differentiation of neuronal
progenitors are important to understand adult neurogenesis.
Given the potential clinical applications and the limited
understanding of this process, we decided to investigate the
proliferation of progenitor cells and neurogenesis in the dentatescience Society. All rights reserved.
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after transient global cerebral ischemia by labelling dividing
cells with the synthetic thymidine analogue BrdU, which is
incorporated into the DNA of dividing cells in the S phase of the
cell cycle and can be detected immunohistochemically
(Gratzner, 1982; Kuhn et al., 1996). The expression of the
glial marker Glial Fibrillary Acidic Protein (GFAP) was also
studied. To determine the survival and fate of proliferating cells
in the granule cell layer (GCL) of the DG and CA1 newborn
cells were examined 4 weeks after BrdU administration using
confocal microscopy.
Transient global cerebral ischemia was induced by occlusion
of both common carotid arteries (CCA) for 5 min. In the gerbil
brain, the lack of posterior communicating arteries between the
carotid arteries and the vertebral arteries constitutes an
incomplete Circle of Willis. Due to this unique anatomical
structure, the gerbil has been widely used as an animal model to
produce transient global cerebral ischemia following occlusion
of both CCA (Ginsberg and Busto, 1989). However, because of
the presence of substantial genetic heterogeneity in commu-
nicating arteries in gerbils, some animals have partial
communicating vessels between the basilar and carotid
circulations on one side (Wang et al., 2002). According to
this and our results, hippocampal CA1 pyramidal neuronal
death triggers proliferation in CA1 and neurogenesis in the DG,
independently of the reduced blood flow.
2. Materials and methods
2.1. Animal experimental design and BrdU injections
Procedures involving animals were in accordance with the guidelines
established by the European Communities Council Directive of 24 November
1986 (86/609/EEC).
For proliferation studies, adult male mongolian gerbils (Meriones unguicu-
latus; 11–12 weeks of age; Harlan, Barcelona, Spain) weighing 60–65 g were
divided into two groups: animals subjected to 5 min of global cerebral ischemia
(n = 21) and sham operated animals (n = 15). Each group of gerbils was sacrificed
(perfused transcardially) at three different time points after ischemia-reperfusion:
5, 12 and 21 days (n = 5–7 animals per group and time point). Twenty-four hours
before sacrifice, all animals received a single intraperitoneal injection of BrdU
(50 mg/kg dissolved in 0.9% NaCl; Sigma–Aldrich, Steinheim, Germany).
For neurogenesis studies and according to our findings in the proliferation
study, two groups of gerbils were divided as follows. A: sham control (n = 5) and
ischemic animals (n = 7) received daily two intraperitoneal injections of BrdU
(50 mg/kg) during days 4, 5, 6 and 7 post-ischemia and were allowed to survive
for 28 days after the first BrdU injection (32 days after surgery). B: sham control
(n = 5) and ischemic animals (n = 7) received daily two intraperitoneal injec-
tions of BrdU (same dosage) during days 10, 11, 12 and 13 post-ischemia and
were allowed to survive for 28 days after the first BrdU injection (38 days after
surgery). Animals were then anesthetized and perfused.
2.2. Transient global cerebral ischemia
Gerbils were anesthetized with Equithesin (chloral hydrate 4.26%, sodium
pentobarbital 0.96% and magnesium sulfate 2.12%, in aqueous solution with
9.5% ethanol) 3 ml/kg, i.p. (Gaese and Ostwald, 1995, 2001). After a medial
neck incision, both CCA were exposed and occluded with aneurysm clips for
5 min. The clips were then removed to restore cerebral blood flow. The rectal
temperature was controlled with a heating blanket to prevent hypothermia.
Sham operated animals were treated identically, except that CCA were not
occluded after the neck incision and carotid exposure.2.3. Fixation and tissue processing
After anaesthesia animals were perfused transcardially with 100 ml of
saline and 200 ml of 4% paraformaldehyde in phosphate-buffered saline
(PBS). After perfusion, all brains were removed, post-fixed in the same fixative
solution for 1 h at room temperature and cryoprotected in 30% sucrose solution
in phosphate buffer (PB) overnight at 4 8C. Freezing microtome sections (30-
mm-thick) were cut coronally through the entire hippocampus and SVZ, in
series of 5 adjacent sections, collected free-floating and stored in 30% ethylene
glycol, 30% glycerol, and 0.1 M PB at 20 8C until processed for immunos-
taining. Some sections were processed for staining with thionin (Nissl staining)
and diaminobenzidine (DAB) NeuN immunohistochemistry for histological
assessment of neuronal death.
2.4. Immunohistochemistry
2.4.1. Immunofluorescence
Four free floating tissue sections comprising the hippocampal formation of
five animals per group were processed for immunohistochemistry (20 different
sections per group). For BrdU staining, sections were pre-treated for DNA
denaturalization in 2N HCl for 30 min at 37 8C and then rinsed in borate buffer
0.1 M (pH 8.5) for 10 min. Brain sections were washed (3  10 min) with PBS
0.1 M (pH 7.4) and incubated in blocking solution (PBS containing 0.3% Triton
X-100, 0.1% BSA and 2% normal goat serum) for 2 h at room temperature.
Primary and secondary antibodies were diluted in the blocking solution.
Sections were incubated with the primary antibodies for 24 h at 4 8C, washed
with PBS and incubated with the secondary antibodies for 2 h at room
temperature, protected from light. The primary antibodies and the concentration
used were: monoclonal rat anti BrdU (1:300, Accurate Chemical, Westbury, NY,
USA); monoclonal mouse anti GFAP (1:500, Sigma, St. Louis, MO, USA);
monoclonal mouse anti NeuN (1:500, Chemicon, Temecula, CA, USA).
Secondary antibodies used were Alexa fluor 488 donkey anti-rat and Alexa
fluor 546 goat anti-mouse highly cross-adsorbed (both 1:200, Invitrogen-
Molecular Probes, Eugene, Oregon, USA). For double labelling, sections were
incubated at the same time with both primary antibodies and then simulta-
neously with the both respective secondary antibodies. Sections were mounted
on SuperFrost plus microscope slides (Menzel GmbH & Co KG, Braunschweig,
Germany), air dried for 24 h, rinsed in toluene (2  5 min), and cover-slipped
with DPX mounting medium. For better visualization of nuclei, sections were
rinsed 2 min in the DNA marker TOPRO-3 (Suzuki et al., 1997; Martin et al.,
2005), working concentration 4 mM in PBS (Invitrogen-Molecular Probes,
Eugene, Oregon, USA), and then washed 2 min in PBS after mounting.
To ensure comparable immunostaining, sections were processed together at
the same time under the same conditions. For the assessment of non-specific
primary immunostaining, sections from each experimental group were incu-
bated without the primary antibodies; in this case no immunostaining was
observed. We also evaluated non-specific secondary immunostaining incubat-
ing sections with primary and its non-respective secondary antibody; again, no
immunostaining was observed. Fluorescence signals were detected with Nikon
eclipse 800 microscope (Nikon, Japan) and confocal microscope LSM 510
Meta (Carl Zeiss, Germany).
2.4.2. DAB immunohistochemistry
For DAB NeuN immunostaining, free floating sections (2 per animal) were
rinsed in several changes of PBS 0.1 M (pH 7.4), treated with 1% hydrogen
peroxide in PBS during 15 min, preincubated for 2 h in blocking solution (PBS
0.1M, pH 7.4, containing 0.3% Triton X-100, 2% normal goat serum and 0.1%
BSA) and then incubated overnight at 4 8C with the primary antibody, mono-
clonal mouse anti NeuN (1:200, Chemicon, Temecula, CA, USA) in blocking
solution. The sections were then washed in PBS three times and incubated with
the secondary antibody, biotinylated goat-anti-mouse (1:200; Vector Lab., CA,
USA), for 2 h at room temperature. Sections were again rinsed in PBS three
times and the subsequent visualization procedure was performed by the avidin-
biotin complex (ABC) method (Vectastain ABC Kit; Vector Lab., CA, USA)
with diaminobenzidine (DAB) as chromogen (peroxidase substrate kit, Vector
Lab.). Sections were mounted on super frost plus slides, air dried for 24 h,
dehydrated, cleared with xylene and cover-slipped with DPX mounting med-
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(Nikon, Japan).
2.5. Quantification
BrdU-positive cells from single labelled sections were counted along all
SGZ of the dentate gyrus from five animals per group, four sections per animal
(20 different sections per group) using 20 objective and the image analyzer
software ‘‘analySIS’’ (Soft Imaging System GmbH, 2003, Germany); the values
were averaged and expressed as mean number of BrdU+ cells in SGZ of the DG.
Fluorescent double and triple labelling was observed in slices using con-
focal microscopy under 40 and 63 objectives. All double and triple labelling
colocalization was confirmed by 3D analysis rotating the images along each
axis and evaluating the sections in Z-series (0.5 mm steps) using LSM 510Fig. 1. Proliferation in the dentate gyrus (DG). (A–L) Representative confocal imag
NeuN (red), BrdU (green) and merged (NeuN-BrdU). (M–P) Representative confocal
showing similar areas of the DG. (A, E, I, M) Sham-control animals; (B, F, J, N) 5 da
ischemia. NeuN stain shows adult neurons in GCLs and hilus of the DG and BrdU
proliferation 5 and 12 days after ischemia in SGZ (F and G, respectively) compared
BrdU+ cells in SGZ do not correspond to astrocytes (M–P) because they do not c
colocalization GFAP-BrdU in the SGZ BrdU+ cells was confirmed by scanning throu
the same panel showing that there is no GFAP-BrdU colocalization. There is a marked
ischemia (N–P) compared to sham (M). GCL: granular cell layer, SGZ: subgranular z
legend, the reader is referred to the web version of the article.).Meta software (Carl Zeiss, Germany). We analyzed 287 BrdU+ cells from
BrdU-GFAP labelled sections in CA1 subfield 5 days after ischemia (5 animals,
3 sections per animal). For asses neurogenesis we perform a semi-quantification
of the triple positive cells (BrdU-NeuN-TOPRO-3) in the granule cell layer
(GCL) of the DG; triple positive cells were counting in a sampling area of
20037.19 mm2 of GCL using LSM 510 Meta software (Fig. 7A) from rando-
mised sections of four groups of study: sham 32 and 38 days after surgery;
ischemia 32 and 38 days after CCA occlusion.
2.6. Statistical analysis
Results, reported as means  S.E.M., were analyzed using one-way
ANOVA followed by post hoc comparisons with the Scheffe´ test. The level
of statistical significance was set at p < 0.05.es of the DG of hippocampus showing immunofluorescent double labelling for
images of the immunofluorescent double labelling for GFAP (red)-BrdU (green)
ys after ischemia; (C, G, K, O) 12 days after ischemia; (D, H, L, P) 21 days after
labelling shows proliferative cells in SGZ of the DG. Note the increased cell
to sham (E) and that this reaction is maximal at 12 days (G). Also note that the
olocalize with GFAP and do not have astrocytic morphology (the absence of
gh three planes). The right insert in O is a higher-magnification view of the box in
increase of GFAP immunoreactivity in the hilus of the DG at all time point after
one. Scale bar = 50 mm (For interpretation of the references to color in this figure
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3.1. Proliferation studies
Proliferation was defined as the number of newborn cells
measured 24 h after a single injection of BrdU. Ischemic
animals showed an increase in the number of proliferating cells
in SGZ of the DG at 5 and 12 days after ischemia; these BrdU+
cells were not astrocytes because they did not express GFAP
(Fig. 1). The number of BrdU+ cells in SGZ of the sham
animals 5 days after surgery was 18.7  2.5 (mean  S.E.M.),
this number increased to 34.6  2.2 in the ischemic animals 5
days after ischemia, p < 0.05 (one-way ANOVA followed by
Sheffe´ test). The number of BrdU+ cells in SGZ of the sham
animals 12 days after surgery was 20.1  2.2, which increased
to 47.5  2.5 in the ischemic animals 12 days after ischemia,
p < 0.05 (one-way ANOVA followed by Sheffe´ test). The
increase in the number of BrdU+ cells in case of ischemia was
maximal at 12 days after ischemia 47.5  2.5, p < 0.05 vs. the
5 day time point, 34.6  2.2 (one-way ANOVA followed byFig. 2. (A) Counting of BrdU+ cells in SGZ. The histogram shows the number of B
controls and ischemic animals. The values indicate absolute counts (mean  S.E.M.)
the 5 day time point (one-way ANOVA followed by Sheffe´ test). (B) Delay
immunohistochemistry using diaminobenzidine. Note the extensive and clear dela
by arrows) compared with sham or ischemic animals 24 h after the ischemic insulSheffe´ test). Then, ischemia increased, significantly, the cell
proliferation in SGZ of the DG at 5 and 12 days after ischemia
and a maximal increase was observed 12 days after ischemia
(Fig. 2A).
In previous studies we corroborated clearly the delayed
neuronal death in CA1 pyramidal cell layer after 5 min of
bilateral CCA occlusion in our model (Fig. 2B). A remarkable
cellular proliferation was found in CA1 5 days after ischemia
compared to sham controls. This cell proliferation was not
observed either 12 or 21 days after ischemia in this
hippocampal subfield. To ensure that our finding in CA1
corresponded to gerbils that really developed neuronal death in
this area we performed this part of the study on sections with
double labelling for BrdU and NeuN. Only sections where
neuronal death was present (demonstrated by loss of NeuN
labelling in CA1) showed the increase in cell proliferation 5
days after ischemia (Fig. 3).
We also examined the SVZ 5, 12 and 21 days after ischemia
(data not shown), looking for an eventual migration from this
well-known proliferative zone to the hippocampus. We did notrdU labelled cells in SGZ of the dentate gyrus at different time points in sham
per dentate gyrus. *p < 0.05 vs. the corresponding sham controls, +p < 0.05 vs.
ed CA1 neuronal death after ischemia. Nissl-stained sections and NeuN
yed neuronal loss of CA1 pyramidal neurons 72 h after ischemia (indicated
t. Scale bars = 250 mm.
Fig. 3. Proliferation in CA1. Representative confocal images from CA1 area of the hippocampus, showing immunofluorescent staining for NeuN (red), BrdU (green)
and merged. NeuN stain shows adult neurons in CA1 pyramidal cell layer (CA1 Py, indicated by dashed lines) and BrdU labelling shows proliferative cells. (A, E, I)
Sham-control animals; (B, F, J) 5 days after ischemia; (C, G, K) 12 days after ischemia; (D, H, L) 21 days after ischemia. Note the loss of NeuN staining in ischemic
animals (B–D) compared to sham (A) and the marked increase of cell proliferation in CA1 5 days after ischemia (F). Also note that there is no colocalization of NeuN-
BrdU in any cell 24 h after BrdU injection (J–L). The left insert in (J) is a higher magnification view and 3D analysis of the central smallest BrdU+ cell in the box,
demonstrating that this cell is in a different Z plane of the NeuN stained cells. Scale bar = 50 mm (For interpretation of the references to color in this figure legend, the
reader is referred to the web version of the article.).
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between sham-controls and ischemic animals at any time point;
only a few ectopic cells were found 5 and 12 days after ischemia.
There was also a marked astrocytic reaction in CA1 in all
sections from gerbils subjected to cerebral ischemia and
showing delayed pyramidal neuronal death, this reaction was
independently of time after ischemia (Fig. 4B and D). Given the
marked cell proliferation found in CA1 5 days after ischemia
and the increase in GFAP immunoreactivity at all time points,
double immunohistochemistry for GFAP and BrdU was also
performed in sections from animals sacrificed 5 days after
ischemia in order to identify eventual astrocytic features of
newborn cells at this time. We analyzed 287 BrdU+ cells from
the group ‘‘ischemia’’: 32% of BrdU(+) cells showed
colocalization with GFAP, i.e. approximately one third of the
newborn cells found in CA1 5 days after ischemia were
astrocytes (Fig. 4E and F).
3.2. Neurogenesis studies
The presence of newly born neurons was demonstrated
analyzing the morphology, anatomic localization and cell pheno-
type by triple fluorescent labelling (NeuN-BrdU-TOPRO-3)of the newborn cells 28 days after the first BrdU injection, a long
enough time for neuronal differentiation. We found triple NeuN-
BrdU-TOPRO-3 positive cells with typical normal neuronal
morphology and anatomic localization of the granule neurons of
GCL of the DG, indicating neurogenesis in this cerebral area
(Fig. 5A–H).
In basal conditions, there was no neurogenesis in CA1
(Fig. 5I–L). However, triple colocalization of NeuN-BrdU-
TOPRO-3 was also observed in CA1 pyramidal layer 32 days
after the transient ischemic insult (Fig. 5M–P). We found one or
two of these cells along ischemic CA1 pyramidal layer
(Fig. 6A–F). The colocalization of neurogenesis markers in
CA1 was found in ischemic animals that received injections of
BrdU during days 4, 5, 6 and 7 post-ischemia and was not
observed in ischemic animals that received injections of BrdU
during days 10, 11, 12 and 13 post-ischemia.
Interestingly, seven brains of different ischemic animals
(from all ischemic groups) developed CA1 pyramidal neuronal
death only in one hemisphere; i.e. seven gerbils subjected to
5 min of bilateral CCA occlusion did not show CA1 pyramidal
neuronal death in one brain hemisphere. In the hippocampus
from hemispheres without neuronal death, neither proliferation
nor neurogenesis changes in CA1 (Fig. 6G–I) or DG (not
Fig. 4. Increased GFAP immunoreactivity in ischemic CA1 area. (A–D) Representative examples of single immunofluorescent labelling for GFAP (green), showing
astrocytes in CA1 area (CA1 pyramidal cell layer is indicated by dashed lines). (A and C) Sham control animals at different magnification, (B) 5 days after ischemia,
(D) 12 days after ischemia. Note the important GFAP immunoreactivity increase after ischemia. (E) confocal image of the double immunofluorescent staining for
GFAP (red) showing astrocytes, and BrdU (green) that shows proliferative cells in CA1 area 5 days after ischemia. (F) Enlarged view of the region indicated by the
box in (E). Note the double-positive cells indicated by arrows in (F). Also note that not all of the BrdU positive cells are astrocytes. Scale bars: A and B = 50 mm, C
and D = 100 mm, E and F = 20 mm (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the article.).
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same brains (hemispheres with CA1 pyramidal neuronal death)
showed however the proliferation and neurogenesis findings in
CA1 and DG reported in this study.
Our semi-quantification of neurogenesis in the DG showed,
in line with previous findings (Liu et al., 1998; Takagi et al.,
1999; Yagita et al., 2001; Sharp et al., 2002; Kokaia and
Lindvall, 2003), increased neurogenesis in the dentate gyrus of
ischemic animals compared to sham controls (Fig. 7). The
number of new neurons was not different between the two
sham-control groups: a mean (S.E.M.) value of 3.7  0.5 newneurons/20037.19 mm2 of GCL was found. Ischemia increased
this number to 8.4  1.2 new neurons/20037.19 mm2 of GCL in
the group of animals that received injections of BrdU during
days 4, 5, 6 and 7 post-ischemia. In the group of animals that
received injections of BrdU during days 10, 11, 12 and 13 post-
ischemia, neurogenesis increased to 12.3  1.7 new neurons/
20037.19 mm2 of GCL. It should be kept in mind that 12 days
after ischemia corresponded to the time point for maximal
increase in proliferation in the DG, whereas 5 days after
ischemia corresponded to the time point for the marked cellular
proliferation observed in CA1.
Fig. 5. Colocalization of NeuN-BrdU-TOPRO-3 in the DG and CA1. Representative confocal images of the immunofluorescent triple labelling for NeuN (red), BrdU
(green) and TOPRO-3 (blue) showing the DG (A–H) and CA1 (I–P) 28 days after the first BrdU injection. (A–D) GCL of the DG 32 days after ischemia; (E–H)
Enlargement by laser of an adjacent area; note the two triple positive cells in H, indicating new neurons. (I–L) CA1 pyramidal cell layer from sham-control animals;
note that the BrdU(+) cell indicated by arrow in (J, K and L) do not express NeuN (I), it may correspond to a new endothelial cell like those indicated by the arrowhead
in (K). (M–P) CA1 pyramidal cell layer 32 days after ischemia; note the loss of neurons (NeuN staining) in ischemic animals compared to sham-controls (I–L) and the
triple positive cell indicated by arrows (the right inset in P is a higher-magnification view and the 3D-analysis of this cell). We confirmed the validity of the triple-
positive cells by scanning through three planes. All scale bars = 20 mm (For interpretation of the references to color in this figure legend, the reader is referred to the
web version of the article.).
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In the present study, we show that CA1 pyramidal cell layer
death induces neurogenesis in dentate gyrus of gerbils and
proliferative reaction in CA1 independently of the reduced
cerebral blood flow.
One important issue with respect to the animal model used in
this study is the presence of small vessels in the ventral surface
of the midbrain that provide communication passages between
the basilar and carotid circulations; this communication is
sufficient to permit blood flowing into the carotid system
despite bilateral CCA occlusion (Ginsberg and Busto, 1989).
These connections may differ significantly from one side of the
brain to the other side; which explains that seven animals did
not show bilateral CA1 pyramidal neuronal death. Indian ink
and monitoring of regional cerebral blood flow (rCBF) by laserDoppler flowmetry have been used to mark the blood vessels in
the gerbil brain and the presence of communicating arteries
which correlate to an incomplete cessation of rCBF after CCA
transient occlusion (Wang et al., 2002). In most gerbils,
forebrain rCBF fell to near zero after CCA occlusion, and the
percent decrease nearly reached 100%. Because different
degrees of arterial connections could be observed between the
basilar and carotid circulations on one side, has been assigned
grading score from 0 to 3: 0, none; 1, thin: 2, medium; 3, thick;
indicate the degree of arterial connection; gerbils with score of
3 did not show delayed neuronal death in CA1 despite bilateral
CCA occlusion. Nevertheless, these same animals (gerbils with
score of 3) have a percent decline in forebrain rCBF of 75%
(Wang et al., 2002) indicating that there is reduced cerebral
blood flow (75% less) but not CA1 neuronal death in the same
forebrain. In our study, we found increased neurogenesis in the
Fig. 6. CA1 32 days after ischemia. Representative confocal images from CA1 area of the hippocampus 32 days after ischemia, showing immunofluorescent staining
for NeuN (red), BrdU (green) and merged. (A, B, C) Low magnification of CA1 pyramidal cell layer indicated by a line in (A); note the difference between the number
of neurons in CA1 and in the rest of cell layers corresponding to CA2 and CA3 were there is not neuronal loss after ischemia. (D, E, F) Laser higher magnification of
the same region. Note that the cell indicated by arrowheads in all panels is the same cell, demonstrating the colocalization of NeuN-BrdU in some cells that were found
in the area of neuronal loss 32 days after ischemia. (G, H, I) CA1 pyramidal cell layer from one of the brain hemispheres subjected to ischemia but that not developed
neuronal death. Note that there is no neuronal loss, proliferation or neurogenesis in this hippocampal region despite the bilateral CCA occlusion. Scale bars: A, B,
C = 50 mm; D, E, F = 10 mm; G, H, I = 20 mm (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the
article.).
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death, which is widely known (Liu et al., 1998; Takagi et al.,
1999; Yagita et al., 2001; Sharp et al., 2002; Kokaia and
Lindvall, 2003), but in the 7 ischemic brain that did not show
bilateral CA1 pyramidal neuronal death, the increased
neurogenesis was observed only in the side of the brain that
shows CA1 pyramidal neuronal death, demonstrated by loss of
CA1 neurons in the same sections. Furthermore, all of the
findings described in this paper in the ischemic groups (marked
CA1 cell proliferation, increased proliferation in SGZ of the
DG, increase of reactive astrocytes in CA1 and DG, and
increased neurogenesis in DG) were observed only on the side
of the ischemic brains that developed CA1 death. We must keep
in mind that even if these seven brains had the most score for
degree of arterial connection (score 3) suggesting the presence
of extensive communicating arteries, these brains will show areduced forebrain rCBF of 75% after CCA occlusion. Then, we
hypothesize that all of the findings described here, including the
increased neurogenesis in the DG are a result of the CA1
pyramidal neuronal death and not of the reduced forebrain
rCBF, so the ischemic pyramidal neuronal death in the CA1
subfield of the hippocampus could trigger neurogenesis
independently of the reduced cerebral blood flow. This fact
is important because it is indicating that the proliferation cell
reactions and the neurogenesis described here are responses of
the adult brain to the neuronal death, independently of the cause
of the death and that it could occur in other neurodegenerative
diseases that course with neuronal death. Liu et al. (1998) have
reported that neurogenesis can occur in the DG of gerbils even
without neural damage in CA1 after transient global ischemia;
this apparent discrepancy may be explained by the different
procedures and concepts used. The above authors used a model
Fig. 7. Neurogenesis in the dentate gyrus. Representative confocal images of the immunofluorescent double labelling for NeuN (red), BrdU (green) and merged
showing neurogenesis in GCL. The blue channel (TOPRO-3) is not shown here for better visualization. (A, E, I) Sham 32 days after surgery; (B, F, J) Sham 38 days
after surgery; (C, G, K) 32 days after ischemia; (D, H, L) 38 days after ischemia. Animals sacrificed at 32 days received BrdU injections 4–7 days post surgery or
ischemia. Animal sacrificed at 38 days received BrdU injections 10–13 days post surgery or ischemia. Newborn neurons, identified by morphology, anatomic
localization and double positive labelling are indicated by arrows. Note the increase in the number of newborn neurons in case of ischemia (K and L) with respect to
sham groups (I and J) and that it is maximal in (L). The left insert in (L) is a higher-magnification view and 3D-analysis of the cell in the box demonstrating the
colocalization of NeuN-BrdU in this granular neuronal shaped cell. GCL: granule cell layer of the dentate gyrus indicated by the box in (A); the box also correspond to
the sampling area of GCL used for counting (20037.19 mm2). Scale bar = 50 mm (For interpretation of the references to color in this figure legend, the reader is
referred to the web version of the article.).
P. Salazar-Colocho et al. / Neuroscience Research 61 (2008) 27–37 35of ischemic tolerance: animals were preconditioned with 2 min
of global ischemia and then subjected to 5 min of global
ischemia 3 d later, BrdU was given 8 d after ischemia, and the
animals were killed 1 d later. Then, they measured proliferation
(number of BrdU positive cells 24 h after the injection of the
mitotic marker), and not neurogenesis (new born neurons).
Moreover, 50% of their animals appeared to have no CA1
neuronal loss.
Of particular importance when using BrdU administration to
study cell proliferation in animals subjected to ischemia, is the
possibility of incorporation of this thymidine analogue into
cells committed to die. In these cells, a response to DNA
damage involves nucleotide excision repair and, if this is
undertaken in the presence of BrdU, the cell can incorporate the
nucleotide (Kuan et al., 2004). Hippocampal CA1 neurons are
particularly sensitive and undergo selective, delayed degenera-
tion in response to transient global ischemia (Kirino, 1982;
Hara et al., 1993; Ferrer et al., 1997). Accordingly, we found a
profound and selective loss of neurons, evaluated by Nissl
staining (not shown) and NeuN labelling in this region 72 h
after ischemia induction. However, at all time points consideredin proliferation studies neither the pyramidal neurons of CA1
showed a colocalization of BrdU-NeuN nor the BrdU+ cells in
CA1 5 days after ischemia had a normal pyramidal shape
(Fig. 3J). With respect to neurogenesis studies, all the BrdU+
cells in the DG have appropriate shape and anatomic
localization 28 days after first BrdU injection (Fig. 7). These
observations suggest that the BrdU+ cells found in CA1 5 days
after ischemia and in the DG 32 and 38 days after injury are new
proliferating cells and do not correspond to preexisting neurons
committed to die.
After ischemia in the gerbil, other studies have reported a
marked increase in cell proliferation in SGZ of the DG,
assessed by the number of cells labelled with BrdU in a 24 h
period, which is maximal around 11 days after injury (Sharp
et al., 2002). In line with these previous data, we found an
enhanced cell proliferation in the SGZ, which was maximal at
12 days after ischemia, and, moreover a marked cell
proliferation in gerbil CA1 subfield 5 days after ischemia.
However, in the SVZ we did not find significant cell
proliferation at the times considered after injury, although a
few ectopic migrating cells could be detected; indicating that
P. Salazar-Colocho et al. / Neuroscience Research 61 (2008) 27–3736the proliferative reaction in CA1 did not correspond to
migrating cells from SVZ as others have suggested (Gould
et al., 1999; Schmidt and Reymann, 2002). Also, in our
proliferation studies BrdU injection was performed 24 h before
sacrifice, a too short time for cell migration from the DG or
SVZ to CA1. In the DG, newly generated neurons migrate from
SGZ to GCL to become granule neurons after approximately 28
days (Ming and Song, 2005).
The increased GFAP immunoreactivity found in the DG and
CA1 from ischemic animals (Figs. 1N–P and 4, respectively) in
agreement with other studies (Herrmann et al., 2000; Yasuda
et al., 2004; Tatsumi et al., 2005) may correspond to activated
astrocytes after ischemic insult. But although it is accepted that
glial cells are activated after brain ischemia, also it is known
that multipotent neural precursors have astrocytic morphology
and express GFAP, i.e., that GFAP labelling may also
correspond to adult neural stem cells (Sun et al., 2003;
Alvarez-Buylla and Lim, 2004; Brazel and Rao, 2004; Picard-
Riera et al., 2004; Steiner et al., 2004; Ming and Song, 2005). In
line with this, some of double BrdU-GFAP positive cells that
were increased in CA1 5 days after ischemia may correspond to
neural stem cells or neuronal resident progenitors. Only 32% of
BrdU+ cells showed colocalization with GFAP 5 days after
ischemia, indicating that there exists more than one cellular
type in the proliferative reaction (Fig. 4). Another cell type that
could be participating in this reaction is the microglia.
Nevertheless, 32 days after ischemia we found triple NeuN-
BrdU-TOPRO-3 positive cells in CA1 (Figs. 5M–P and 6)
although few. It is described that proliferating cells differentiate
into neurons in the hippocampal CA1 region of gerbils after
global cerebral ischemia (Schmidt and Reymann, 2002). Then,
these cells could represent new neurons which might originate
from progenitor cells in the parenchyma of this subfield. In situ
activation of endogenous progenitors, located in both the CA1
periventricular region and parenchyma, after intraventricular
infusion of FGF-2 and EGF leads to regeneration of pyramidal
CA1 neurons after ischemic injury (Nakatomi et al., 2002).
Several studies have also demonstrated the production of new
neurons in regions other than SGZ or SVZ of the adult
mammalian brain (Palmer et al., 1999; Gage, 2000; Magavi
et al., 2000; Pencea et al., 2001; Yamamoto et al., 2001; Eisch,
2002; Tonchev et al., 2003; Emsley et al., 2005; Ming and Song,
2005). However to establish that these cells in CA1 are new
neurons, that are integrated into the existing brain circuitry and
contribute to ameliorating neurological deficits, more studies
like electrophysiology and behavioural tests are needed.
On the basis of our findings in proliferation studies, we chose
an adequate regime of BrdU administration allowing the study
of the neurogenesis process in our experimental model (4–7 or
10–13 days post-ischemia). The increased neurogenesis found
in GCL of the DG of ischemic animals was more marked in the
group of animals that received injections of BrdU during days
10–13 post-ischemia (Fig. 7). Given that 12 days after injury
correspond to the time point for maximal increase in SGZ
proliferation (Figs. 1 and 2), it seems that this matches the
increased neurogenesis in GCL. Colocalization of neurogenesis
markers (NeuN-BrdU-TOPRO-3) and increase in the numberof BrdU+ cells were detected in CA1 from ischemic animals
that received BrdU injections 4–7 days post-ischemia and not in
animals receiving BrdU 10–13 days post ischemia, which also
matches the time of maximal proliferation (5 days) found in this
region (Fig. 3).
In conclusion, this study support the notion that under
appropriate conditions, neurogenesis may be mediated by
endogenous adult neural progenitors resident in brain areas,
such as CA1 or SGZ of the DG, and that this process is triggered
in response to neuronal death. In this line, we hypothesize that
this response would be independent of the cause of cell death.
This opens up the possibility of attaining a treatment that
enhances neurogenesis in situ against this or another class of
neuronal death by manipulating these resident progenitors. The
normal absence of constitutive neurogenesis does not reflect an
intrinsic limitation for the potential of endogenous neural
precursors, which may be activated by appropriate neurogenic
intrinsic signals triggered by pathological conditions and,
probably, also by exogenous manipulation. This may represent
an interesting opportunity for regenerative therapies for stroke
and other neurological diseases.
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